The tool's in-depth analysis of RNA molecules will provide better information of the connections between mutant genetic material and disease
The developer of molecular diagnostic tests reported Q4 revenues of $49.3 million, down from $52.9 million in the year-ago quarter
Guardant Health will acquire Bellwether Bio, in a deal designed to advance the buyer’s pipeline of early-detection cancer diagnostics.
Thermo Fisher Scientific and The Wellcome Trust Sanger Institute develop an array to capture genome-wide variation in African populations
Company accused of submitting false claims to Medicare for the Decipher prostate cancer test between September 2015 and June 2017
High-Throughput Method Developed by UC San Francisco and Broad Researchers Allows for the Screening of Complex Genetic Interactions.
German researchers break new ground in the understanding of chromothirpsis, implicating the failure of a cell's genetic repair system
Researchers use data from 275,000 women for a genome-wide association study that found seven variants specific to ER-negative breast cancer
Companies aim to accelerate commercialization of CDx and therapeutics, as well as leverage their experience with regulators
Researchers refine what they know about cancer by using C. elegans as a model system for studying DNA mismatch repair in greater detail